These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 4605278
1. The influence of haloperidol and penfluridol on the learning capacity of the schizophrenic. Van Lommel R, Baro F, Dom R. Arzneimittelforschung; 1974 Jul; 24(7):1072-4. PubMed ID: 4605278 [No Abstract] [Full Text] [Related]
2. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach. Baro F, Van Lommel R, Dom R, De Mesmaecker L. Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015 [No Abstract] [Full Text] [Related]
3. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial. Zwanikken GJ. Psychiatr Neurol Neurochir; 1973 Mar; 76(2):83-92. PubMed ID: 4573494 [No Abstract] [Full Text] [Related]
4. The interaction between neuroleptic treatment and sociotherapeutic approach in chronic schizophrenics. Investigations with haloperidol, penfluridol and pimozide. Baro F, Dom R. Acta Psychiatr Belg; 1976 Mar; 76(5):735-58. PubMed ID: 1030923 [Abstract] [Full Text] [Related]
5. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia. Vandecasteele AJ, Vereecken JL. Acta Psychiatr Scand; 1974 Mar; 50(3):346-53. PubMed ID: 4609288 [No Abstract] [Full Text] [Related]
6. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia. Jus A, Pineau R, Jus K, Villeneuve A, Gautier J, Pires P, Drolet A, Cote M, Villeneuve R. Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617 [No Abstract] [Full Text] [Related]
10. Penfluridol: an efficacious long-acting oral antipsychotic compound. Gallant DM, Mielke DH, Spirtes MA, Swanson WC, Bost R. Am J Psychiatry; 1974 Jun; 131(6):699-702. PubMed ID: 4597305 [No Abstract] [Full Text] [Related]
11. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)]. Bruck J, Guss H. Int Pharmacopsychiatry; 1974 Jun; 9(3):152-65. PubMed ID: 4154320 [No Abstract] [Full Text] [Related]
14. [Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data]. Mormont C. Acta Psychiatr Belg; 1972 Sep; 72(5):595-601. PubMed ID: 4669431 [No Abstract] [Full Text] [Related]
15. [Long term neuroleptic therapy using fluspirilene and penfluridol]. Haase HJ, Fischer D, Floru L, Frank T, Joseph K, Knaack M, Mohr W, Richter-Peill H, Steuer A, Wahl G, Walterbusch G, Zurborn R. Nervenarzt; 1971 Dec; 42(12):632-7. PubMed ID: 5134761 [No Abstract] [Full Text] [Related]
16. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses. Svestka J, Náhunek K. Act Nerv Super (Praha); 1972 Dec; 14(2):93-4. PubMed ID: 4557145 [No Abstract] [Full Text] [Related]
18. [Clinical experiences with an oral, long-term neuroleptic agent: penfluridol]. Floru L, Zurborn R. Med Welt; 1973 Apr 13; 24(15):600-3. PubMed ID: 4744987 [No Abstract] [Full Text] [Related]
19. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent. Ota KY, Kurland AA, Slotnick VB. J Clin Pharmacol; 1974 Apr 13; 14(4):202-9. PubMed ID: 4595986 [No Abstract] [Full Text] [Related]
20. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate]. Angst J, Woggon B. Arzneimittelforschung; 1975 Feb 13; 25(2):267-70. PubMed ID: 1091272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]